KEITH A SCOTT
Allopathic & Osteopathic Physicians|Family Medicine ABBEVILLE, SC NPI 1740280718
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine SC ABBVIE INC. All categories
General Payments — all program years on this page
$5,418.60
- Category: General Payments
- Program years: PY2018–2024
- Record count: 342
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $983.21 across 52 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $983.21 | 52 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $184.09 | 14 |
| Lundbeck LLC | $137.34 | 5 |
| Otsuka America Pharmaceutical, Inc. | $96.64 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $85.82 | 4 |
| Lilly USA, LLC | $64.76 | 3 |
| GlaxoSmithKline, LLC. | $52.10 | 3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $47.83 | 3 |
| ABIOMED | $41.46 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $41.34 | 2 |
| SK Life Science, Inc. | $35.45 | 1 |
| Daiichi Sankyo Inc. | $29.14 | 1 |
| ARGENX US, INC. | $24.40 | 1 |
| Novo Nordisk AS | $22.55 | 1 |
| EISAI INC. | $22.05 | 1 |
| DEXCOM, INC. | $21.09 | 1 |
| Merck Sharp & Dohme Corporation | $17.59 | 1 |
| Amgen Inc. | $17.28 | 1 |
| Acerta Pharma LLC | $15.30 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.56 | 1 |
| Corcept Therapeutics | $13.42 | 1 |
By program year
Records — PY2024 (52)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.